$VREX

Kunkel Jay K. sold $150K of VREX

Kunkel Jay K. sold 8,121 shares of Varex Imaging Corp (VREX) at $18.48 ($0.15M total) on 2026-09-14.

Original reporting
SEC EDGAR · Kunkel Jay K.
Published Sep 15, 2026, 9:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VREX
Neutral
medium confidence
Mentioned
$VREX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VREXNeutralLow
01

Why it matters

The director's sale is modest and unlikely to move the stock materially.

02

Market read

Routine insider sale with limited trading impact.

03

What to watch

If the director is reallocating capital, it may not reflect company fundamentals.

Relevance 4/10Novelty 4/10Timing: filing posted on Sep 15, 2026 (post‑market)

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$VREXNeutralMedium confidence
Context

Director Jay K. Kunkel sold 8,121 shares of Varex Imaging for $150,076, reducing his stake to 15,329 shares.

Expected impact

Potential modest downside pressure in short term.

Evidence & confidence

The sale size is small relative to market cap and does not indicate broader concerns.

Market effects

None significant for the imaging equipment sector.

No regional effect.

Minimal.

Counterpoint

Insider sales can be routine; the market may ignore this filing.

Key entities

  • Varex Imaging Corp

    US‑listed medical imaging equipment manufacturer (ticker VREX).

  • Jay K. Kunkel

    Director of Varex Imaging.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDYHighAI 9/10

Los Angeles Business Journal

Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.

$TDYMedAI 9/10

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

$TDYMedAI 9/10

Teledyne Technologies to Acquire Varex Imaging

Teledyne Technologies agreed to acquire all outstanding shares of Varex Imaging under a definitive deal approved unanimously by both boards. Varex makes X-ray sources and digital detectors plus imaging software for medical and industrial inspection. The deal is expected to close in early 2027, pending regulatory and Varex stockholder approval.